Weldon Steven W 4
4 · GT Biopharma, Inc. · Filed May 14, 2020
Insider Transaction Report
Form 4
Weldon Steven W
DirectorCFO
Transactions
- Sale
common stock
2020-05-13$0.00/sh−2,269,708$2,270→ 4,500,000 total
Footnotes (1)
- [F1]The disposal of the 2,269,708 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018.